These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9890045)

  • 21. Early history of regulatory requirements for poultry biologics in the United States.
    Espeseth DA; Lasher H
    Avian Dis; 2010 Dec; 54(4):1136-43. PubMed ID: 21313831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The American manufacturer's view on the EEC texts and harmonization.
    Draayer HA; Hilsabeck LJ; Miller RH
    Dev Biol Stand; 1992; 79():77-83. PubMed ID: 1286768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Licensing of veterinary vaccines.
    Fries HH
    Acta Vet Scand Suppl; 1996; 90():83-4. PubMed ID: 8996892
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulatory framework and requirements for managing risks associated with veterinary biological products in Africa: present systems and future needs.
    Sylla D; Rweyemamu MM; Palya VJ
    Rev Sci Tech; 1995 Dec; 14(4):1171-84. PubMed ID: 8639954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of the EEC directive (81/852)--quality.
    Lee AM
    Dev Biol Stand; 1992; 79():39-41. PubMed ID: 1286763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. License requirements for recombinant DNA veterinary biologics in U.S.A.
    La Salle B
    Dev Biol Stand; 1985; 59():181-4. PubMed ID: 4007277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legislation covering the licensing of veterinary medicines in the United Kingdom.
    Morgan WJ
    Vet Rec; 1983 Oct; 113(14):310-3. PubMed ID: 6649346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resource directory--pharmacy. Licensing requirements.
    Healthc Trends Transit; 1991 Feb; 2(3):46-7. PubMed ID: 10112086
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 1990; 800():1-221. PubMed ID: 2124759
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of international and regional organisations in the regulation of veterinary biologicals.
    Blancou J; Truszczynski M
    Rev Sci Tech; 1995 Dec; 14(4):1193-206. PubMed ID: 8639956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral Drug Association statement to the Food and Drug Administration Center for Biologics Evaluation and Research on the General Biologics Licensing Regulations January 26, 1995.
    PDA J Pharm Sci Technol; 1995; 49(3):101-2. PubMed ID: 7613985
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of the Office International des Epizooties in the standardisation of biologicals.
    Truszczynski M; Blancou J
    Dev Biol Stand; 1992; 79():95-8. PubMed ID: 1286770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDA comments. "Review of general biologics licensing regulations". Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1995; 49(2):59-61. PubMed ID: 7780745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Regulatory aspects of the development, licensing, and availability of immunological veterinary medicinal products].
    JungbMck C; Werner E; Von Messling V
    Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):473-7. PubMed ID: 26697714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of Veterinary Services tests of biologics 1978-1979.
    Price RJ
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):63-5. PubMed ID: 298938
    [No Abstract]   [Full Text] [Related]  

  • 37. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A
    Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National considerations in the Nordic countries regarding vaccine licensing.
    Gunnarsson E; Lund A; Høy T; Larsson B; Sihvonen L
    Acta Vet Scand Suppl; 1996; 90():85-7. PubMed ID: 8996893
    [No Abstract]   [Full Text] [Related]  

  • 39. Confirming the safety characteristics of recombinant vectors used in veterinary medicine: a regulatory perspective.
    Gay CG; Roth HJ
    Dev Biol Stand; 1994; 82():93-105. PubMed ID: 7958487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Good manufacturing practice for immunological veterinary medicinal products.
    Todd JI
    Rev Sci Tech; 2007 Apr; 26(1):135-45. PubMed ID: 17633298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.